Novartis nears $70-plus per share deal to acquire Avidity Biosciences, Bloomberg News reports-March 2024-www.financetom.com

Novartis nears $70-plus per share deal to acquire Avidity Biosciences, Bloomberg News reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novartis nears $70-plus per share deal to acquire Avidity Biosciences, Bloomberg News reports

Oct 26, 2025 8:37 AM

Oct 26 (Reuters) - Swiss drugmaker Novartis AG

is close to acquiring U.S. biotech Avidity Biosciences ( RNA )

for over $70 per share, Bloomberg News reported on Sunday,

citing a person familiar with the matter.

Reuters could not immediately confirm the report.

Previous page： Analog Devices Insider Sold Shares Worth $1,455,357, According to a Recent SEC Filing Next page： Accounting software firm BlackLine's Q3 revenue slightly beats expectations

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Analog Devices Insider Sold Shares Worth $1,455,357, According to a Recent SEC Filing

Nov 6, 2025

05:05 PM EST, 11/06/2025 (MT Newswires) -- Ray Stata, Director, on November 04, 2025, sold 6,250 shares in Analog Devices ( ADI ) for $1,455,357. Following the Form 4 filing with the SEC, Stata has control over a total of 791,667 common shares of the company, with 139,446 shares held directly and 652,221 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/6281/000090072925000010/xslF345X05/wk-form4_1762464041.xml ...

Accounting software firm BlackLine's Q3 revenue slightly beats expectations

Nov 6, 2025

Overview * BlackLine ( BL ) Q3 revenue grows 7.5%, slightly beating analyst expectations * GAAP net income and EPS decline compared to Q3 2024 * Company repurchased 2.1 mln shares for $113 mln Outlook * BlackLine ( BL ) expects Q4 GAAP revenue between $182 mln and $184 mln * Company forecasts full-year GAAP revenue between $699 mln and...

FIGS Q3 revenue beats analyst estimates driven by higher average order value

Nov 6, 2025

Overview * FIGS Q3 2025 revenue grows 8.2% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 beats estimates, reflecting operational improvements * Company increases full-year 2025 outlook Outlook * FIGS raises full-year 2025 net revenue growth outlook to approximately 7.0% * Company expects full-year 2025 adjusted EBITDA margin above original forecast Result Drivers * REVENUE GROWTH - Driven by...

MP Materials Q3 Adjusted Loss Narrows, Revenue Declines

Nov 6, 2025

05:06 PM EST, 11/06/2025 (MT Newswires) -- MP Materials ( MP ) reported a Q3 adjusted loss late Thursday of $0.10 per diluted share, narrowing from the loss of $0.12 a year earlier. Analysts polled by FactSet expected a loss of $0.17. Revenue in the three months ended Sept. 30 fell to $53.6 million from $62.9 million a year earlier....